Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
5.40
-0.10 (-1.82%)
Sep 11, 2025, 4:00 PM EDT - Market closed
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+85.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +85.19% | Aug 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +455.56% | May 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $60 | Strong Buy | Maintains | $100 → $60 | +1,011.11% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2,400 → $600 | Strong Buy | Maintains | $2,400 → $600 | +11,011.11% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $33,600 | Strong Buy | Initiates | $33,600 | +622,122.22% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $21,600 | Strong Buy | Initiates | $21,600 | +399,900.00% | Sep 14, 2021 |